EUR 0.76
(-1.3%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.02 Million | -3.18 Million | - | -294.98 Thousand | -66.5 Thousand | 126.61 Thousand |
Net Income | -4.88 Million | -2.25 Million | 359.6 Thousand | 67.37 Thousand | 36.6 Thousand | 482.69 Thousand |
Depreciation & Amortization | 17.49 Thousand | 325.29 Thousand | - | 6476.00 | 3006.00 | 1458.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 3.84 Million | -1.26 Million | - | -2.15 Million | -69.97 Thousand | -356.08 Thousand |
Other non-cash items | -1856.00 | -2545.00 | -359.6 Thousand | 1.78 Million | -36.14 Thousand | -1457.00 |
Investing Cash Flow | -1.61 Million | -818.85 Thousand | - | 35.63 Thousand | -279.69 Thousand | 400.00 |
Investments in PPE | -153.15 Thousand | -583.56 Thousand | - | -9229.00 | -22.29 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -1.46 Million | - | - | - | -257.4 Thousand | - |
Sales/Maturities of investments | - | - | - | 44.86 Thousand | - | 400.00 |
Other Investing Activities | 1431.00 | -235.29 Thousand | - | 44.86 Thousand | -257.4 Thousand | 400.00 |
Financing Cash Flow | 82.6 Thousand | -26.77 Thousand | - | 10.7 Million | 4.1 Million | -76.17 Thousand |
Debt repayment | -67.3 Thousand | -27.77 Thousand | - | -1.26 Million | -1.08 Million | -173.82 Thousand |
Dividends payments | - | - | - | - | - | -250 Thousand |
Common Stock Repurchased | - | - | - | - | - | -139.84 Thousand |
Common Stock Issuance | - | - | - | 9.44 Million | 5.19 Million | -173.82 Thousand |
Other Financing Activities | 149.9 Thousand | 1000.00 | - | 10.7 Million | -1.00 | 661.3 Thousand |
Accounts receivables | 7.14 Million | -2.39 Million | - | -2.11 Million | 698.6 Thousand | 1.48 Million |
Accounts payables | -1.52 Million | - | - | -734.81 Thousand | -509.61 Thousand | 612.34 Thousand |
Inventory | -55.07 Thousand | -351.9 Thousand | - | -42.53 Thousand | -6452.00 | -1179.00 |
Other working capital | -3.24 Million | 1.49 Million | - | 734.81 Thousand | -252.5 Thousand | -2.45 Million |
Cash at beginning of period | 8.11 Million | 12.14 Million | 14.39 Million | 3.95 Million | 329.37 Thousand | 140.73 Thousand |
Cash at end of period | 5.55 Million | 8.11 Million | 12.1 Million | 14.39 Million | 3.95 Million | 191.57 Thousand |
Capital Expenditure | -153.15 Thousand | -583.56 Thousand | - | -9229.00 | -22.29 Thousand | - |
Effect of forex changes on cash | - | - | - | 1.00 | -1.00 | - |
Net cash flow / Change in cash | -2.55 Million | -4.03 Million | -2.29 Million | 10.44 Million | 3.62 Million | 50.83 Thousand |
Free Cash Flow | -1.17 Million | -3.77 Million | - | -304.21 Thousand | -88.8 Thousand | 126.61 Thousand |
Breakdown | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.14 Million | -2.74 Million | -2.33 Million | -2.25 Million | 85.44 Thousand | 359.6 Thousand |
Depreciation & Amortization | 93.1 Thousand | 77.64 Thousand | 66.07 Thousand | 101.19 Thousand | 35.12 Thousand | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.84 Million | 2.71 Million | - | - | -1.36 Million | - |
Other non-cash items | -141.86 Thousand | -726.39 Thousand | 2.33 Million | 2.25 Million | 2.86 Million | -359.6 Thousand |
Investing Cash Flow | -764.07 Thousand | -851.85 Thousand | - | - | -523.98 Thousand | - |
Investments in PPE | -70.58 Thousand | -82.57 Thousand | - | - | -538.48 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -693.48 Thousand | -779.98 Thousand | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -769.28 Thousand | - | - | 14.5 Thousand | - |
Financing Cash Flow | 189.11 Thousand | -106.51 Thousand | - | - | -92.71 Thousand | - |
Debt repayment | -44.21 Thousand | -111.51 Thousand | - | - | -87.71 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 144.9 Thousand | 5000.00 | - | - | -5000.00 | - |
Accounts receivables | 4.39 Million | 3.71 Million | - | - | -2.77 Million | - |
Accounts payables | -811.02 Thousand | -713.14 Thousand | - | - | -34.04 Thousand | - |
Inventory | -20.48 Thousand | -34.59 Thousand | - | - | 3929.00 | - |
Other working capital | -1.71 Million | -967.01 Thousand | - | - | 1.43 Million | - |
Cash at beginning of period | 1.37 Million | 8.11 Million | 10.27 Million | 12.1 Million | 4.64 Million | 14.39 Million |
Cash at end of period | 452.89 Thousand | 6.47 Million | 8.11 Million | 8.11 Million | 274.35 Thousand | 12.1 Million |
Capital Expenditure | -70.58 Thousand | -82.57 Thousand | - | - | -538.48 Thousand | - |
Effect of forex changes on cash | - | 8.11 Million | - | - | 12.14 Million | - |
Net cash flow / Change in cash | -923.83 Thousand | -1.63 Million | -2.16 Million | -3.98 Million | -4.37 Million | -2.29 Million |
Free Cash Flow | -419.46 Thousand | -758.69 Thousand | 132.14 Thousand | 202.39 Thousand | -1.79 Million | - |
002595
SANU
DBIS
MEDICAMEQ
OGN
OVCHY